28 results on '"Lisiak, Magdalena"'
Search Results
2. The Impact of Rationing Nursing Care on Patient Safety: A Systematic Review.
- Author
-
Uchmanowicz, Izabella, Lisiak, Magdalena, Wleklik, Marta, Pawlak, Andrzej Maciej, Zborowska, Agnieszka, Stańczykiewicz, Bartłomiej, Ross, Catherine, Czapla, Michał, and Juárez-Vela, Raúl
- Published
- 2024
- Full Text
- View/download PDF
3. The concurrent impact of mild cognitive impairment and frailty syndrome in heart failure
- Author
-
Uchmanowicz, Izabella, primary, Rosano, Giuseppe, additional, Piepoli, Massimo, additional, Vellone, Ercole, additional, Czapla, Michał, additional, Lisiak, Magdalena, additional, Diakowska, Dorota, additional, Prokopowicz, Anna, additional, Aleksandrowicz, Krzysztof, additional, Nowak, Bernadetta, additional, Wleklik, Marta, additional, and Faulkner, Kenneth, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure
- Author
-
Krysztofiak, Helena, Wleklik, Marta, Migaj, Jacek, Dudek, Magdalena, Uchmanowicz, Izabella, Lisiak, Magdalena, Kubielas, Grzegorz, Straburzyńska-Migaj, Ewa, Lesiak, Maciej, and Kałużna-Oleksy, Marta
- Subjects
Heart Failure ,Aging ,Sarcopenia ,Cachexia ,Review ,Comorbidity ,cardiac cachexia ,musculoskeletal system ,Prognosis ,nutritional status ,Europe ,Risk Factors ,Chronic Disease ,Quality of Life ,Humans - Abstract
Heart failure (HF) is a common complication of various cardiac diseases, and its incidence constantly increases. This is caused mainly by aging of populations and improvement in the treatment of coronary artery disease. As HF patients age, they tend to develop comorbidities, creating new problems for health-care professionals. Sarcopenia, defined as the loss of muscle mass and function, and cachexia, defined as weight loss due to an underlying illness, are muscle wasting disorders of particular relevance in the heart failure population, but they go mostly unrecognized. The coexistence of chronic HF and metabolic disorders facilitates the development of cachexia. Cachexia, in turn, significantly worsens a patient’s prognosis and quality of life. The mechanisms underlying cachexia have not been explained yet and require further research. Understanding its background is crucial in the development of treatment strategies to prevent and treat tissue wasting. There are currently no specific European guidelines or recommended therapy for cachexia treatment in HF (“cardiac cachexia”).
- Published
- 2020
5. Frailty Syndrome in Older Adults with Cardiovascular Diseases–What Do We Know and What Requires Further Research?
- Author
-
Wleklik, Marta, primary, Denfeld, Quin, additional, Lisiak, Magdalena, additional, Czapla, Michał, additional, Kałużna-Oleksy, Marta, additional, and Uchmanowicz, Izabella, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Polish Adaptation of the Self-Care of Diabetes Inventory (SCODI)
- Author
-
Uchmanowicz, Izabella, Krzemińska, Sylwia, Ausili, Davide, Luciani, Michela, Lisiak, Magdalena, Uchmanowicz, I, Krzeminska, S, Ausili, D, Luciani, M, and Lisiak, M
- Subjects
reliability ,Patient Preference and Adherence ,diabetes ,self-care ,MED/45 - SCIENZE INFERMIERISTICHE GENERALI, CLINICHE E PEDIATRICHE ,Diabete ,Self-Care of Diabetes Inventory ,Original Research - Abstract
Izabella Uchmanowicz,1 Sylwia KrzemiÅska,1 Davide Ausili,2 Michela Luciani,2,3 Magdalena Lisiak1 1Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland; 2Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 3Department of Public Health and Pediatrics, University of Turin, Torino, ItalyCorrespondence: Izabella UchmanowiczDepartment of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, PolandTel +48 71 784 18 05Fax +48 71 345 93 24Email izabella.uchmanowicz@umed.wroc.plPurpose: As the guidelines indicate, education and self-care in diabetic patients are essential elements in the treatment process. The efficient evaluation of the level of self-care will enable the patient’s needs to be identified and education and care to be optimised. The Self-Care of Diabetes Inventory (SCODI) is a valid and reliable tool which can measure self-care behaviours among patients with diabetes. The purpose of this study was to assess the reliability of the Polish version of the SCODI.Methods: The World Health Organization (WHO) translation protocol was used for the translation and cultural adaptation of the English version of the SCODI into Polish. The study included 276 Polish patients with type 2 diabetes (mean age 61.28± 12.02 years). There were 145 men and 131 women in the study. The internal consistency of the SCODI was evaluated using Cronbach’s Alpha.Results: The original four actor tool structure was confirmed. The mean overall levels of self-care in the four SCODI scales in the study group were self-care maintenance (67.66 pts; SD=18.55), self-care monitoring (61.81 pts; SD=24.94), self-care management (54.65 pts; SD=22.98) and self-care confidence (62.86 pts; SD=20.87). The item-total correlations were positive, so there is no need to change the scales of any of the questions. The overall consistencies for individual scales were assessed using Cronbach’s Alpha: self-care maintenance (0.759), self-care monitoring (0.741), self-care management (0.695) and self-care confidence (0.932). Exploratory factor analysis and item factor loadings of the individual items ranged from 0.137 to 0.886 and, with two exceptions (questions number 23 and 32), were statistically significant (p< 0.05).Conclusion: The SCODI questionnaire has acceptable internal consistency and reliability in assessing self-care among diabetic patients in the Polish population. This reliable research tool can be managed in planned studies of Polish patients with diabetes.Keywords: Self-Care of Diabetes Inventory, reliability, self-care, diabetes
- Published
- 2020
7. Cognition and Frailty in Patients With Heart Failure: A Systematic Review of the Association Between Frailty and Cognitive Impairment
- Author
-
Faulkner, Kenneth M., primary, Uchmanowicz, Izabella, additional, Lisiak, Magdalena, additional, Cichoń, Ewelina, additional, Cyrkot, Tomasz, additional, and Szczepanowski, Remigiusz, additional
- Published
- 2021
- Full Text
- View/download PDF
8. The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome
- Author
-
Uchmanowicz,Izabella, Lisiak,Magdalena, Wleklik,Marta, Gurowiec,Piotr, and KaÅużnaâOleksy,Marta
- Subjects
Aged, 80 and over ,Male ,Frailty ,Frail Elderly ,Risk Assessment ,humanities ,acute coronary syndrome ,frailty syndrome ,Cross-Sectional Studies ,quality of life ,Tilburg Frailty Indicator ,Clinical Interventions in Aging ,Surveys and Questionnaires ,Humans ,Female ,Prospective Studies ,Non-ST Elevated Myocardial Infarction ,Original Research ,Aged - Abstract
Izabella Uchmanowicz,1 Magdalena Lisiak,1 Marta Wleklik,1 Piotr Gurowiec,2 Marta KaÅużna–Oleksy31Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw 51-618, Poland; 2Department of Nursing, Public Higher Medical Professional School in Opole, Opole 45-060, Poland; 31st Cardiology Department, University Hospital of Lord‘s Transfiguration Partner, PoznaÅ University of Medical Sciences, Poznan 61-848, PolandPurpose: Elderly patients with ST-segment-elevation myocardial infarction (STEMI) have a high risk of mortality, which is particularly high in the first 30days. Quality of life (QoL) and risk-benefit assessments are of pivotal importance in the elderly. The objective of this study is to assess the relationship between frailty syndrome (FS) and QoL in patients following acute coronary syndrome (ACS) non-ST elevation myocardial infarction (NSTEMI).Patients and Methods: The study involved 100 patients (61 men, 39 women, the average age: M±SD =66.12±10.92years). The study used standardized research tools: a questionnaire to assess QoL (World Health Organization Quality of Life Scale Brief version), and a questionnaire to assess FS (Tilburg Frailty Indicator).Results: FS occurred in 80% of patients after ACS. FS has a negative impact on the QoL of patients with ACS. The most important domain of FS in the studied group was the psychological: M±SD=2.2±0.75 points. The greater FS in the physical domain, the lower the QoL in all areas. The greater FS in the social domain, the lower the QoL in psychological and social fields. Self-evaluation of patient QoL was M±SD=3.68±0.71 points. Self-assessment of health was M±SD=2.59±0.98 points.Conclusion: Patients with a coexisting FS have a poorer QoL in the physical, psychological, social, and environmental fields. For a multidisciplinary team, these findings can help make the therapeutic decision for frail patients who have poor QoL. Frailty among elderly patients with ACS can be considered as a determinant of high risk of adverse outcomes.Keywords: frailty syndrome, quality of life, acute coronary syndrome, Tilburg Frailty Indicator
- Published
- 2019
9. New-generation drug eluting stent vs. bare metal stent in saphenous vein graft – 1 year outcomes by a propensity score ascertainment (SVG Baltic Registry)
- Author
-
Wańha, Wojciech, Roleder, Tomasz, Mielczarek, Maksymilan, Ładziński, Szymon, Milewski, Marek, Chmielecki, Michał, Gilis-Malinowska, Natasza, Ciećwierz, Dariusz, Bachorski, Witold, Kunik, Piotr, Trznadel, Agata, Genc, Alicja, Januszek, Rafał, Dziewierz, Artur, Bartuś, Stanisław, Gruchała, Marcin, Smolka, Grzegorz, Dudek, Dariusz, Navarese, Eliano Pio, Ochała, Andrzej, Jaguszewski, Miłosz, Wojakowski, Wojciech, Gasior, Pawel, Gierlotka, Marek, Szczurek-Katanski, Krzysztof, Osuch, Marcin, Hawranek, Michał, Gasior, Mariusz, Polonski, Lech, Ochijewicz, Dorota, Tomaniak, Mariusz, Kołtowski, Lukasz, Rdzanek, Adam, Pietrasik, Arkadiusz, Jakala, Jacek, Legutko, Jacek, Huczek, Zenon, Filipiak, Krzysztof, Opolski, Grzegorz, Kochman, Janusz, Roleder, Magda, Jędrychowska, Magdalena, Plens, Krzysztof, Surdacki, Andrzej, Lisiak, Magdalena, Uchmanowicz, Izabella, Paszek, Elżbieta, Zajdel, Wojciech, Żmudka, Krzysztof, Kuźma, Łukasz, Kożuch, Marcin, Kralisz, Paweł, Nowak, Konrad, Pogorzelski, Szymon, Róg-Makal, Magdalena, Struniawski, Krzysztof, Bachórzewska-Gajewska, Hanna, Dobrzycki, Sławomir, Kalińczuk, Łukasz, Proczka, Michał, Zieliński, Kamil, Mintz, Gary S., Dębski, Mariusz, Markiewicz, Michał Gwidon, Sieradzki, Bartek, Pręgowski, Jerzy, Dębski, Artur, Łazarczyk, Hubert, Ciszewski, Michał, Chmielak, Zbigniew, Dzielińska, Zofia, Demkow, Marcin, Witkowski, Adam, Śpiewak, Mateusz, Trochimiuk, Piotr, Miłosz, Barbara, Mazurkiewicz, Łukasz, Trzciński, Adam, Teresińska, Anna, Marczak, Magdalena, Wolny, Rafał, Tyczyński, Paweł, Proniewska, Klaudia, Pregowska, Agnieszka, van Dam, Peter, Szczepanski, Janusz, Henzel, Jan, Bujak, Sebastian, Moszura, Tomasz, Kryczka, Karolina, Kaczmarska-Dyrda, Edyta, Broy-Jasik, Beata, and Kurowski, Andrzej
- Subjects
10-P ,12-P ,11-P ,13-P ,2-P ,3-P ,4-P ,5-P ,1-P ,6-P ,7-P ,8-P ,9-P ,Abstracts of Original Contributions - Abstract
Background Data regarding the efficacy of percutaneous coronary intervention (PCI) with new-designed drug eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare 1-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. Methods We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year. This observation included 792 consecutive patients (mean age: 69 ±8.9 years), treated with either new-DES (n = 379, 47.9%) or BMS (n = 413, 52.1%). Results In unmatched cohort patients treated with new-DES vs. BMS had lower MACCE (28.3% vs. 21.4%, HR = 0.69, 95% CI: 0.50–0.95, p = 0.025) as well as myocardial infarctions (MI) (12.1% vs. 6.3%; HR = 0.49, 95% CI: 0.30–0.82, p = 0.005) at 1 year. After propensity score matching similar, significant reduction in MACCE and MI was sustained in new-DES vs. BMS groups (HR = 0.66, 95% CI: 0.46–0.96, p = 0.030; and HR = 0.53, 95% CI: 0.31–0.92, p = 0.020, respectively). Conclusions In patients undergoing PCI of SVG, the use of new-DES is associated with a reduced 1-year rate of MACCE and MI compared to BMS., Background Presence of durable polymers may be associated with late/very late stent thrombosis occurrence and the need for prolonged dual antiplatelet therapy. Bioresorbable polymers may facilitate stent healing, thus enhancing clinical safety. Aim We sought to determine the 3-year clinical follow-up in patients treated with the thin strut (71 μm) bioabsorbable polymer-coated sirolimus-eluting (BP-SES) stent versus durable coating everolimus eluting stent (DP-EES) in daily clinical routine. Methods Interventional Cardiology Network Registry is a multicenter, all-comers registry of 21.400 patients treated with PCI between 2010 and 2016. All patients who underwent implantation of either ALEX (n = 287) or XIENCE (n = 1114) stents within a time frame of availability of 3-year clinical follow-up were included. We evaluated the incidence of all-cause deaths at 3-year follow-up and a composite endpoint of death or myocardial infarction. Results There was no significant differences between the groups in procedure related complications and in-hospital mortality (ALEX 1.8% vs. XIENCE 1.0%, p = 0.22). Follow-up demonstrated similar 3-year all-cause mortality (ALEX 12.0% vs. XIENCE 11.9%, p = 0.99), as well as comparable incidence of composite endpoint in ALEX group when compared to XIENCE (19.9% vs. 20.0%, p = 0.98, respectively). Conclusions In this multicenter registry, ALEX stent demonstrated comparable clinical outcomes at 3 years after implantation to the XIENCE stent. These data support the relative long-term safety and efficacy of ALEX in a broad range of patients undergoing percutaneous coronary interventions., Background Peri-strut low intensity areas (PLIA) surrounding metallic stents struts, visualized by optical coherence tomography (OCT) images, have been related to inflammation, neointimal proliferation and increased incidence of target lesion revascularization. Aim To determine the association between PLIA by OCT and the vascular healing response after bioresorbable scaffold (BRS) implantation in the setting of acute myocardial infarction (MI). Methods This is a single-centre, longitudinal study with a serial: baseline, 12- and 24-month OCT evaluation of neointimal response after percutaneous coronary intervention (PCI) with BRS implantation in patients presenting with ST-segment elevation MI (STEMI). Neointimal thickness and area were evaluated in relation to the presence of PLIA by OCT. Every analyzed cross section was scored: 0 – no PLIA; 1 – PLIA in < 1 quadrant; 2 – PLIA in 1 but < 2 quadrants; 3 – PLIA in 2 but < 3 quadrants; 4 – PLIA in ≥ 3 quadrants. A total of 18 STEMI patients treated with 20 AbsorbBRS implantation were included. Results The presence of PLIA within the scaffolds was identified in 55%. The significant positive correlation was found between PLIA score and the mean (r = 0.406; p = 0.038), maximal (r = 0.421; p = 0.032) and minimal neointimal thickness (r = 0.426; p = 0.03), but not with neointimal area (r = –0.091; p = 0.352) after 24 months. No difference was observed between the PLIA positive and negative group in terms of the neointimal thickness and area. Conclusion In STEMI patients treated with BRS implantation, presence and extent of PLIA by OCT may be associated with the pattern of neointimal formation. This surrogate parameter may serve as a tool for evaluation of in-scaffold neointimal growth after future generation BRS implantation. Figure 1 Peri-strut low intensity area (PLIA) score classification on the optical coherence tomography (OCT). The analyzed cross sections were scored: 0 – no signs of PLIA; 1 if PLIA in < 1 quadrant; 2 if PLIA in 1 but < 2 quadrants; 3 if PLIA in 2 but < 3 quadrants; and 4, if PLIA in ≥ 3 quadrants, Background The biodegradable polymer drug-eluting stents were developed to improve vascular healing. However, further data is needed to confirm the safety and efficacy of these stents in patients with acute myocardial infarction (AMI). Aim We sought to determine the 1-year clinical follow-up in patients with AMI treated with the thin strut biodegradable polymer-coated sirolimus-eluting (BP-SES) stent versus durable coating everolimus-eluting stent (DP-EES). Methods We analyzed patients with AMI (STEMI and NSTEMI) treated with either a BP-SES (ALEX™, Balton, Poland, n = 886) or DP-EES (XIENCE™, Abbott, USA, n = 1054) with available 1-year clinical follow-up using propensity-score matching. Outcomes included target vessel revascularization (TVR) as efficacy outcome and all-cause death, myocardial infarction, and definite/probable stent thrombosis as safety outcomes. Results After propensity score matching 672 patients treated with BP-SES and 672 patients treated with DP-EES were selected. Procedural and clinical characteristics were similar between both groups. In-hospital mortality was similar in both tested groups. One-year follow-up demonstrated comparable efficacy outcome TVR (BP-SES 7.1% vs. DP-EES 5.2%, p = 0.14), as well as similar safety outcomes of all-cause death, myocardial infarction, and definite/probable stent thrombosis. Conclusions The thin-strut biodegradable polymer coated sirolimus-eluting stent demonstrated comparable clinical outcomes at 1-year after implantation to the DP-EES. These data support the relative safety and efficacy of BP-SES in high-risk ACS patients undergoing PCI., Background Myocardial infarction with non-obstructive coronary arteries (MINOCA) remains still challenging mainly due to its complex and multiple etiology. Aim To assess the relationship between gender and clinical outcomes during follow-up in patients after MINOCA and predictors of main adverse cardiac and cerebrovascular adverse events (MACCE). Methods The study consisted of 134 patients (78 females, 58.2%) at the mean age of 61.6 years who were diagnosed with MINOCA in our department of cardiology within the period from January 2015 to June 2018. The subjects were included in the average follow-up period lasting 609.5 days. The primary study endpoints were MACCE, which included death, myocardial infarction, reintervention and cerebral stroke. The evaluated secondary study endpoints were recurrent chest pains in the follow-up period and rehospitalization for reasons other than MACCE. Additionally, we assessed predictors of primary and secondary study endpoints. Results The MINOCA frequency is presented in Figure 1. Kaplan Meier survival curve analysis did not reveal statistically significant differences in the frequency of MACCE (p = 0.63) or mortality rate (p = 0.29) between males and females during follow-up period. There was no statistically significant impact of gender on secondary study endpoints during the follow-up. Univariate and multivariate analysis of predictors of primary and secondary study endpoints has not included gender among other confirmed predictors of clinical outcomes during follow-up in patients after MINOCA. Figure 1 MINOCA frequency stratified by sex and year of enrollment Conclusions Despite a number of clinical differences and comorbid diseases between genders in patients after MINOCA, gender was not found to be significantly associated with clinical outcomes during the follow-up., Background Frailty syndrome (FS) is an exponent of advanced biological age and an important risk factor for the development of adverse outcomes. The multi-factor cascade of the change process should be considered in the context of both biological and psychological as well as socio-environmental factors. In connection with the above, it is indicated increasingly the importance of a new phenomenon which is cognitive impairment (CI) associated with co-existing FS, so-called cognitive frailty (CF). The heterogeneity of FS and CI is one of the risk factors for cardiovascular events. This can be extremely important in elderly patients with the acute coronary syndrome (ACS) because patients with CF may not meet the therapeutic goals. Aim To describe the association between FS and CI in elderly patients with ACS. Methods This prospective observational study included one-hundred patients aged 65 or older hospitalized for ACS. Frailty was assessed using the Tilburg Frailty Indicator (TFI). The Mini-Mental State Examination (MMSE) was used for cognitive function evaluation (study results are presented in Tables I-IV). Table I Characteristics of participants Mean (SD) Median (min.-max.) P-value 76.08 (8.24) 77 (68–84) 0.004 Mean age of women = 78.43 years old, mean age of men = 73.87 years old. Table II Results of the TFI questionnaire TFI Women (n = 48) Men (n = 52) All (n = 100) P-value n % n % n % Frail 36 73.47 24 46.15 60 60.00 0.01 No frail 12 25.00 28 53.85 40 40.00 The mean total TFI score = 6.98. Table III Cognitive impairment in patients with frailty syndrome FS CI (n = 40) No CI (n = 60) P-value n % n % Frail 36 90.00 24 40.00 < 0.001 No frail 4 10.00 36 60.00 Females 50% > Males 30%. Table IV Domain of the TFI questionnaire in patients with cognitive impairment Domain CI N Mean SD Median Min. Max. Q1 Q3 P-value* Physical + 40 6.17 1.52 6 2 8 5.75 7 < 0.001 – 60 3.48 2.08 3 0 8 2 5 Psychological + 40 2 0.93 2 0 3 1 3 0.001 – 60 1.28 0.98 1 0 3 1 2 Social + 40 0.92 0.86 1 0 3 0 1 0.655 – 60 0.8 0.68 1 0 2 0 1 Conclusions Cognitive frailty occurred in the studied population of patients with ACS. There is a negative relationship between the presence of FS (especially in the physical and psychological domain of the TFI) and CI. It is worth mentioning that there is still a lack of sufficient studies on the cognitive frailty in patients with ACS. The obtained results may be helpful in optimizing the care plans and implementing interventions to improve physical and psychological functioning in patients with co-existing cognitive frailty., Background Profilin 1 (Pfn 1) is a small protein crucial in the regulation of actin cytoskeleton. Several studies show it may play a role in gene expression and intracellular communication, being released from platelets and possibly other cells (endothelium, leukocytes). An increasing amount of data suggests Pfn 1 is a key player in the pathogenesis of stable angina and acute coronary syndrome. A basic factor influencing the treatment and prognosis of patients with type 1 myocardial infarction (t1MI) is the duration of symptoms of ischemia. In everyday clinical practice, it is often difficult to determine this parameter, due to a number of patient-related factors (e.g. unclear symptom onset, stress, etc). Therefore, it is reasonable to search for a laboratory indicator of symptom duration. Methods 65 patients with t1MI (STEMI or NSTEMI) treated with pPCI were enrolled in the study. The exclusion criteria were: inability to define the time of symptom onset; symptom duration > 24 h; s/p CABG; active inflammation; any thrombosis, stroke or MI within the last 3 months; neoplasms; hypercoagulability; stage 4 or 5 chronic kidney disease. Pfn 1 concentration in peripheral blood was assessed using an enzyme-linked immunosorbent assay (ELISA) in three time points: on admission, 24 and 48 h post pPCI. Results We found a negative correlation between symptom duration and Pfn 1 concentration on admission (Spearman R = –0.42, p = 0.008), 24 h post pPCI (Spearman R = –0.30, p = 0.022) and 48 h post pPCI (Spearman R = –0.28, p = 0.033). Patients presenting with symptoms lasting less than 6 h had a significantly higher concentration of Pfn 1 than those with symptoms lasting longer than 6 h (838.54 vs. 687.12, p = 0.007). Conclusions To our knowledge, this is the first study investigating the relationship between Pfn 1 and symptom duration in both STEMI and NSTEMI patients. We have shown that Pfn 1 concentration in peripheral blood is inversely proportional to symptom duration, probably due to release from activated platelets during intracoronary thrombus formation. Pfn 1 may be an objective indicator of the symptom duration in MI, and as such could be a a valuable tool in decision-making and prognostic assessment., Background Epidemiology of valvular hearth defects has changed in recent years. Aging of the population has contributed to the increase of the percentage of both, degenerative defect and coronary heart disease. Due to the lack of current data on coronary artery disease among patients with valvular diseases in Podlaskie region this study gathers information about this group of patients. Aim The analysis of the atherosclerotic plaque burden distribution in the coronary arteries and long term prognosis among patients with valvular heart disease. Methods Retrospective analysis considered medical documentation of 12954 patients hospitalized in the Department of Invasive Cardiology of the Medical University of Bialystok. Follow-up of total morality was done after the average of 1500 days. Results Valvular heart disease was diagnosed in 1214 patients, among whom 843 subjects had coronary artery disease. Mitral regurgitation was the most common valvular defect, which, at different severity grading, occurred at 50% of the studied population (n = 607). The most common severe valvular heart defect was aortic valve stenosis, which affected 23% of patients (n = 279). Combined valvular heart disease occurred in 44.7% patients (n = 543), of which 29.5% (n = 358) had a disease of more than one valve. Significant coronary artery narrowings were diagnosed in 524 patients. Angiographicaly significant stenoses were mostly reported in LAD (25.25%, n = 303), Cx, (23.91%, n = 287) and RCA (23.66%, n = 284). There were 236 percutaneous coronary interventions (19,6%), with the prevailing PCI of Cx (n = 139) and LAD (n = 93). The operation due to valvular heart defects was performed in 47.98% patients, and 41.06% of those underwent coronary artery bypass surgery. Significant stenosis of the right coronary artery was more frequently diagnosed among patients who died (21.77% vs. 31.38%, p < 0.001). Subjects with severe mitral valve insufficiency more often presented with the diagonal artery stenosis. Conlcusions The most common defect in the analysed population was mitral regurgitation of all grading severity. Aortic valve stenosis was the most severe valvular heart defect and presented with significantly worse prognosis comparing to other heart diseases despite lower risk of death. Coronary artery disease was an additional factor worsening the prognosis of patients with heart defects. More than 50% of patients underwent coronary revascularization. Significant stenosis of diagonal artery more frequently occurred in mitral insufficiency, and significant stenosis of right coronary artery worsened the prognosis. During 8-year follow-up 19.7% of subjects died., Background Both IVUS and FFR are been used to assess the clinical importance of a borderline coronary lesion. It has been suggested that more lesions are significant when assessed using IVUS than when using FFR. Methods Consecutive pts with borderline, de novo coronary lesions (%DS ≥ 40%, but < 70%) from the ANIN IVUS & FFR registries were analyzed. Cut-off values of significance were an IVUS minimum lumen area (MLA) < 3.0 mm2 and minFFR < 0.8. Results Between 1/2009 to 12/2016 there were 1225 patients with 1547 borderline lesions (880 IVUS; 667 FFR). IVUS was almost exclusively preferred for left main (LM) lesions (p < 0.001); but other coronaries were examined with both techniques equally (Figure 1). After exclusion of 408 pts with LM lesions, those examined with FFR were significantly older, had more hypertension and hyperlipidemia, but had less previous PCI. Mean MLA was 4.2 ±1.8 mm2, and mean minFFR was 0.83 ±0.09. Overall, 31.8% of LAD lesions were significant because of an IVUS MLA < 3.0 mm2 or an minFFR < 0.8 vs. 19.5% in RCA and 21.2% in LCx (p = 0.001). More lesions were significant by FFR vs. IVUS (32.6% vs. 23.9%; p = 0.002), especially in the LAD; whereas RCA lesions were considered significant more frequently by IVUS, and LCx lesions were significant with similar frequency by both techniques (Figure 1). Figure 1 Distribution of IVUS, FFR, MLA < 3.0 mm2 and FFR < 0.8 among the coronary arteries Conclusions The saying “If you want to treat, use IVUS. If you don’t, use FFR” is clinically untrue using contemporary criteria, especially when recognizing specific vessel differences. Use of IVUS for borderline verification does not lead to more intervention as compared to FFR assessment., Background Stress perfusion CMR or SPECT are used for assessment of myocardial ischemia. Methods Consecutive pts in whom induced ischemia (expressed as a % of left ventricular (LV) mass) was established using SPECT (SYMBIA INTEVO EXCEL) or MR (1.5T scanner, Philips Gyro-Scan NT) with different methods of inducing stress were analyzed and compared. Results From 2013 to 2017, 696 patients (65.2 years; 29.0% males) were studied with CMR; from 2016 to 2017, 690 patients (66.5 years; 31.0% males) were studied with SPECT. Ischemia of any level was more frequently identified using SPECT vs. CMR (72.3% vs. 31.5%; p < 0.001). However, total ischemia burden was greater with CMR vs. SPECT (10% (9% to 15%) vs. 5% (3% to 6%); p < 0.001). Also, ≥ 10% ischemia was identified more frequently with CMR vs. SPECT (22.7% vs. 9.6%; p < 0.001) and more frequently with dipyridamole (p = 0.028, Figure 1). Comparing patients with inducible ischemia by SPECT vs. CMR, there were more patients with a history of chronic renal disease (14.9% vs. 8.2%, p = 0.004) and CABG (22.7% vs. 15.7%, p = 0.05), but less MI (43.9% vs. 53.6%, p = 0.033). There was no difference in hypertension, dyslipidemia, or diabetes. Patients with induced ischemia ≥ 10% were less often ≥ 65 years of age (51.3% vs. 61.8%, p = 0.048), but more often had diabetes (32.5% vs. 25.2%, p = 0.04) or an MI history (55.3% vs. 41.1%, p < 0.001). Figure 1 Distribution of the ischemia burden categorized with various cut-offs and assessed with different imaging modalities Conclusions SPECT is more sensitive in detecting any amount of ischemia, but CMR is more accurate in detecting pts with ≥ 10% LV involvement who have a worse prognosis. CMR identifies more often pts with ischemia involving more than 10% of LV mass while SPECT is a more sensitive technique for detecting the presence of ischemia., Background Even after all the workshop conditions of optimum angiography are fulfilled and even when working with high-resolution angiographic equipment, > 40% of borderline LM lesions have an inconclusive assessment. Methods In 2 orthogonal views (LAO vs. RAO) lumen diameters were measured among borderline LM lesions visualized at 15 f/s with the SiemensTM AXIOM (1024 × 1024 flat panel detector). Identified were the 3 frames within the narrowest region of LM lumenogram (1 back & 1 forward, counting from the one judged as the narrowest). Then, 3 independent measurements were made: minimal lumen diameter (3× MLD) and proximal & distal reference diameters (prox & dist ref diam, 3× each). Measurements were done with image enlarged by a factor of 2, using a dedicated digital caliper (plotting lines from a single pixel to a single pixel to the nearest 2 decimal places). Measurements and %DS (100% – MLD/mean ref diam) were categorized for their minimal and maximal values. Results Among the 32 consecutive patients (67 ±8 years, 53% males), 1567 diameters were measured. Absolute variations in min vs. max measured diameters as displayed on Figure 1. In a per patient analysis relative variations in measured diameters for prox ref, MLD and dist ref led to variations in min vs max %DS in LAO and RAO views of 30 ±14% vs. 49 ±14% (p < 0.001) and 32 ±17% vs. 55 ±13% (p < 0.001), respectively. Conclusions Even using contemporary coronary angiographic equipment, assessment of LM stenosis severity (as well as LM reference lumen size) is highly variable. The inherent limitations of angiography lead to inconsistency in LM stenosis severity assessment. Figure 1 Variations in measured minimal (solid) vs. maximal (transparent) diameters at the sites of: prox ref (◻), MLD (○) and dist ref (◊) (on a per frame (A) & per patient basis (B)) (p < 0.001 for all corresponding comparisons of min vs. max), Background In primary care, 10–20% of people complain of significant sleep problems, with nearly 100 identified types of sleep disorders. A number of factors lead to under-detection of sleep deprivations. Its effective diagnosis is important to receive the correct treatment. Aim To proposed original concept of the infrastructure of the home-care system for sleep identification and sleep event scoring (Figure 1). Figure 1 Block diagram summarizing the steps followed in this study, from signal recording to the biostatistical and Information Theory based analysis Methods This study includes some preliminary results toward ECG-based diagnosis of sleep disorders. Sleep deprivation detection problem is modeled as a two-group classification problem. The two subject groups are: healthy individuals and Sleep Related Breathing Disorders (SRBD) positives (12 subjects). Parameters derived from ECG and acoustic analysis were considered as input for the predictive statistical models used to find the best possible classification of sleep disorders. Moreover, as an alternative to statistical analysis Lempel-Ziv Complexity (LZC) algorithm as detection tool of sleep deprivation via ECG was applied. Results Our results show that the best events recognition is reached for over 89% (raw database) and for over 92% (up-sampled database) good predictions. It turned also out, that the SRBD patients have more regular ECGs, which are characterized by LZC around 0.32, while control group has the complexity around 0.85 and variability of patterns is much larger. Conclusions Proposed diagnostic method, which links biostatistics with Information Theory approach, is a powerful tool for the classification of sleep disorders, even in the early stage. It provides also inspiring insight into developing effective algorithms of telemedical data interpretation., Background Coarctation of the aorta (CoA) is a common cause of secondary arterial hypertension (HTA). Aim To analyze the diagnostic route and medical therapy of HTA in a series of adults undergoing endovascular stenting of CoA. Methods Twenty-four consecutive adults (median age: 36 years, 15 men) were enrolled. Clinical history was collected at baseline, wherein special attention was paid to the time period between onset of HTA and diagnosis of CoA. Patients were contacted by phone after 34 ±17 months to follow up medical treatment. Results The mean age at detection of HTA was 17.1 ±8.8 years (range: 1–36 years), while the mean age at diagnosis of CoA was 33.5 ±14.9 years (range: 1–77). The mean delay in diagnosis was 16.4 ±11.1 years (maximally 37). All patients underwent successful CoA stenting with excellent trans-coarctation gradient reduction (40.1 ±15.9 before the procedure vs. 1.3 ±2.2 mm Hg after the procedure; p < 0.001; 95% CI: 32.1–45.4). No early complications were observed; in 1 case redo intervention was performed due to aortic aneurysm formation. Overall, 95.8% of patients received antihypertensive treatment at baseline (79.2% with ≥ 3 drugs), compared to 65.2% at follow-up (30.4% with ≥ 3 drugs); p = 0.008, Z = –2.65. The mean number of antihypertensives dropped from 3.1 ±1.3 to 1.9 ±1.7 (p < 0.001; 95% CI: 0.67–1.94). The mean number of reduced drugs per patient was 1.3 ±1.4 (Table I). Table I Detailed characteristics of the patients enrolled Patient Sex Age at the intervention [years] Delay in the diagnosis [years] SBP/DBP [mm Hg] Number of antihypertensive drugs Invasive PG [mm Hg] Before stenting After stenting Baseline Follow-up Before stenting After stenting 1† F 77 n/a 140/90 n/a 4 n/a 39 3 2 M 46 10 130/80 130/80 5 5 58 1 3$,# F 26 < 1 140/90 130/70 3 0 25 5 4# M 18## 2 200/120 140/70 2 4 60 6 5 F 41 1 175/84 120/70 3 2 51 4 6 M 30 4 170/75 117/69 5 3 28 0 7 F 35 11 208/87 133/79 3 0 49 1 8 M 26 10 145/80 129/77 3 0 45 0 9* F 35 n/a 162/93 123/76 3 1 48 0 10 M 38 21 169/102 154/109 3 2 70 0 11$ M 41 < 1 170/80 164/96 3 2 62 4 12 M 37 19 175/77 151/91 6 4 33 3 13 F 38 29 135/70 101/73 0 0 39 0 14 M 38 36 150/84 135/70 3 2 25 0 15 M 30 17 182/82 162/84 3 4 18 0 16 M 47 12 131/75 132/75 4 0 39 3 17* F 27 n/a 117/76 101/70 1 0 30 3 18 M 60 30 173/85 120/82 3 0 26 0 19 F 35 16 148/81 122/78 3 2 14 1 20** M 31 n/a 158/68 135/72 4 5 34 1 21 F 27 14 146/84 129/86 2 0 27 0 22** M 41 n/a 144/84 105/67 4 2 24 2 23 M 29 16 144/79 148/77 1 1 67 0 24 M 45 37 149/89 135/87 4 4 57 1 M – male, F – female, SBP – systolic blood pressure, DBP – diastolic blood pressure, PG – pressure gradient, n/a – not available/not applicable † intra-hospital death $ prompt diagnosis of CoA # treated with a bare metal stent ## age at the original intervention * diagnosed in infancy, not operated, ** diagnosed and operated in infancy. Conclusions Delayed diagnosis of CoA leads to unnecessary antihypertensive medication, therefore diagnostics focused on CoA should be carried out in all children and young adults presenting with HTA. Endovascular stenting is a safe and effective treatment strategy for CoA in adults that significantly improves medical treatment.
- Published
- 2018
10. Factors Associated with Heart Failure Knowledge and Adherence to Self-Care Behaviors in Hospitalized Patients with Acute Decompensated Heart Failure Based on Data from “the Weak Heart” Educational Program
- Author
-
Kolasa, Jolanta, primary, Lisiak, Magdalena, additional, Grabowski, Marcin, additional, Jankowska, Ewa A, additional, Lelonek, Malgorzata, additional, Nessler, Jadwiga, additional, Pawlak, Agnieszka, additional, and Uchmanowicz, Izabella, additional
- Published
- 2021
- Full Text
- View/download PDF
11. 'The Weak Heart' as an educational model for patients hospitalized due to decompensation of heart failure with reduced ejection fraction
- Author
-
Kolasa, Jolanta, Uchmanowicz, Izabella, Wleklik, Marta, Lisiak, Magdalena, Lelonek, Małgorzata, Pawlak, Agnieszka, Grabowski, Marcin, Jankowska, Ewa, and Nessler, Jadwiga
- Subjects
disease management ,cardiology ,self-care ,heart failure ,educational model - Abstract
Introduction. KONS (Kompleksowa opieka nad chorymi z niewydolnością serca) is the name of a Polish programme for the coordinated care for patients with heart failure that has been proposed as a complex heart failure management solution based on European Society of Cardiology (ESC) Heart Failure recommendations. The challenge is that there are currently no available systemic solutions for educating these patients. Our project aimed to evaluate the effectiveness of a pilot model of education and telemonitoring known as ‘The Weak Heart’ for patients hospitalised due to decompensation of heart failure with reduced ejection fraction (HFrEF). Materials and methods. ‘The Weak Heart’ educational model consists of three phases: phase I - training and certification of nurses to perform the role of heart failure nurse specialists; phase II - checking the effectiveness of the model in a clinical setting; and phase III - implementation of patient education standards in cardiac centres. Data collected will be used to evaluate the impact of the programme on patients’ understanding regarding heart failure, their compliance with recommendations, and their pro-health behaviours in terms of self-care and self-control. Conclusion. ‘The Weak Heart’ programme will allow conclusions to be drawn concerning the usefulness and effectiveness of the first targeted heart failure-based patient educational model in Poland. Positive results in this pilot project could become the basis for implementing systemic changes, and introducing the model into everyday clinical practice.
- Published
- 2020
12. The relationship between burnout, job satisfaction and the rationing of nursing care—A cross‐sectional study
- Author
-
Uchmanowicz, Izabella, primary, Karniej, Piotr, additional, Lisiak, Magdalena, additional, Chudiak, Anna, additional, Lomper, Katarzyna, additional, Wiśnicka, Alicja, additional, Wleklik, Marta, additional, and Rosińczuk, Joanna, additional
- Published
- 2020
- Full Text
- View/download PDF
13. „W trosce o słabe serce” — model edukacji chorych hospitalizowanych z powodu dekompensacji niewydolności serca ze zmniejszoną frakcją wyrzutową
- Author
-
Kolasa, Jolanta, primary, Uchmanowicz, Izabella, additional, Wleklik, Marta, additional, Lisiak, Magdalena, additional, Lelonek, Małgorzata, additional, Pawlak, Agnieszka, additional, Grabowski, Marcin, additional, Jankowska, Ewa A., additional, and Nessler, Jadwiga, additional
- Published
- 2020
- Full Text
- View/download PDF
14. A curriculum for heart failure nurses: an expert opinion of the Section of Nursing and Medical Technicians and the Heart Failure Working Group of the Polish Cardiac Society
- Author
-
Uchmanowicz, Izabella, primary, Lisiak, Magdalena, additional, Lelonek, Małgorzata, additional, Jankowska, Ewa A., additional, Pawlak, Agnieszka, additional, Jaroch, Joanna, additional, Kolasa, Jolanta, additional, Hetman, Piotr, additional, Straburzyńska-Migaj, Ewa, additional, Czapla, Krystyna, additional, and Nessler, Jadwiga, additional
- Published
- 2020
- Full Text
- View/download PDF
15. Multidimensional Approach to Frailty
- Author
-
Wleklik, Marta, primary, Uchmanowicz, Izabella, additional, Jankowska, Ewa A., additional, Vitale, Cristiana, additional, Lisiak, Magdalena, additional, Drozd, Marcin, additional, Pobrotyn, Piotr, additional, Tkaczyszyn, Michał, additional, and Lee, Christopher, additional
- Published
- 2020
- Full Text
- View/download PDF
16. Psychometric Evaluation Of Appetite Questionnaires In Elderly Polish Patients With Heart Failure
- Author
-
Wleklik, Marta, primary, Lisiak, Magdalena, additional, Andreae, Christina, additional, and Uchmanowicz, Izabella, additional
- Published
- 2019
- Full Text
- View/download PDF
17. Heart Failure and Problems with Frailty Syndrome:: Why it is Time to Care About Frailty Syndrome in Heart Failure
- Author
-
Uchmanowicz, Izabella, Młynarska, Agnieszka, Lisiak, Magdalena, Kałuzna-Oleksy, Marta, Wleklik, Marta, Chudiak, Anna, Dudek, Magdalena, Migaj, Jacek, Hinterbuchner, Lynne, and Gobbens, R.J.J.
- Subjects
older people ,assessment instruments ,Frailty ,heart failure ,prognostic factors ,multidisciplinary care - Abstract
Frailty syndrome (FS) is an independent predictor of mortality in cardiovascular disease and is found in 15-74% of patients with heart failure (HF). The syndrome has a complex, multidimensional aetiology and contributes to adverse outcomes. Proper FS diagnosis and treatment determine prognosis and support the evaluation of treatment outcomes. Routine FS assessment for HF patients should be included in daily clinical practice as an important prognostic factor within a holistic process of diagnosis and treatment. Multidisciplinary team members, particularly nurses, play an important role in FS assessment in hospital and primary care settings, and in the home care environment. Raising awareness of concurrent FS in patients with HF patients and promoting targeted interventions may contribute to a decreased risk of adverse events, and a better prognosis and quality of life.
- Published
- 2019
18. Psychometric Evaluation Of Appetite Questionnaires In Elderly Polish Patients With Heart Failure
- Author
-
Wleklik, Marta, Lisiak, Magdalena, Andreae, Christina, and Uchmanowicz, Izabella
- Subjects
Psychiatry ,nutritional status ,Näringslära ,appetite ,Nutrition and Dietetics ,Patient Preference and Adherence ,elderly ,heart failure ,Psykiatri ,Original Research - Abstract
Marta Wleklik,1 Magdalena Lisiak,1 Christina Andreae,2–4 Izabella Uchmanowicz1 1Department of Clinical Nursing, WrocÅaw Medical University, Wroclaw, Poland; 2Division of Nursing Science, Linköping University, Linköping, Sweden; 3Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; 4Department of Medicine, Region Sörmland, Nyköping, SwedenCorrespondence: Izabella UchmanowiczDepartment of Clinical Nursing, Faculty of Health Sciences, WrocÅaw Medical University, Bartla 5, Wroclaw 51-618, PolandTel +48 71 784 18 24Fax +48 71 341 95 33Email izabella.uchmanowicz@umed.wroc.plPurpose: Loss of appetite is caused by multifaceted disorders and affects an average of 40% of patients with heart failure (HF). The Council on Nutrition Appetite Questionnaire (CNAQ) and the Simplified Nutritional Appetite Questionnaire (SNAQ) are designed to assess appetite among older adults. We aimed to assess the psychometric properties of both CNAQ and SNAQ questionnaires in elderly Polish patients with HF.Methods: The study sample involved 103 patients aged ≥ 65 years with HF diagnosed according to the New York Heart Association (NYHA) functional classes II–IV. The study was conducted among hospitalized patients with HF. In the study, the Mini Nutritional Assessment (MNA) questionnaire was used to assess the validity of the questionnaire. The evaluation of the following psychometric values was taken into account: data quality and homogeneity, factor structure, construct validity and internal consistency.Results: Parallel analysis confirmed the unidimensional structure of both CNAQ and SNAQ. The adjusted eigenvalues for CNAQ were 3.50 for the first factor and 0.62 for the second factor, and for SNAQ they were 2.2 and 0.31, respectively. For CNAQ, the desired CFA values were obtained after modification (RMSEA 0.95), for SNAQ without modification (RMSEA 0.95). The correlation between CNAQ and SNAQ and MNA was strong (rs = 0.8 and rs = 0.81, p
- Published
- 2019
19. BeGuideWell: A prospective cross-sectional study analysing the awareness and opinions of nursing students in Poland on the usefulness of European Society of Cardiology guidelines in post-graduate education programme
- Author
-
Uchmanowicz, Izabella, primary, Wleklik, Marta, additional, Hill, Loreena, additional, Lisiak, Magdalena, additional, Chudiak, Anna, additional, Lomper, Katarzyna, additional, Lambrinou, Ekaterini, additional, Jennings, Catriona, additional, and Fitzsimons, Donna, additional
- Published
- 2019
- Full Text
- View/download PDF
20. Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
- Author
-
Uchmanowicz, Izabella, primary, Młynarska, Agnieszka, additional, Lisiak, Magdalena, additional, Kałuzna-Oleksy, Marta, additional, Wleklik, Marta, additional, Chudiak, Anna, additional, Dudek, Magdalena, additional, Migaj, Jacek, additional, Hinterbuchner, Lynne, additional, and Gobbens, Robbert, additional
- Published
- 2019
- Full Text
- View/download PDF
21. Frailty Syndrome: Nursing Interventions
- Author
-
Uchmanowicz, Izabella, primary, Jankowska-Polańska, Beata, additional, Wleklik, Marta, additional, Lisiak, Magdalena, additional, and Gobbens, Robbert, additional
- Published
- 2018
- Full Text
- View/download PDF
22. Polish Nurses’ Knowledge of Heart Failure Self-Care Education Principles
- Author
-
Jankowska-Polańska, Beata, primary, Brzykowska, Marta, additional, Uchmanowicz, Izabella, additional, Lisiak, Magdalena, additional, and Rosinczuk, Joanna, additional
- Published
- 2017
- Full Text
- View/download PDF
23. Frailty and quality of life in elderly patients with acute coronary syndrome
- Author
-
Uchmanowicz, Izabella, primary, Wontor, Radosław, additional, and Lisiak, Magdalena, additional
- Published
- 2016
- Full Text
- View/download PDF
24. Frailty in patients with acute coronary syndrome: comparison between tools for comprehensive geriatric assessment and the Tilburg Frailty Indicator
- Author
-
Uchmanowicz, Izabella, primary, Lisiak, Magdalena, additional, Wontor, Radosław, additional, and Łoboz-Grudzień, Krystyna, additional
- Published
- 2015
- Full Text
- View/download PDF
25. Frailty Syndrome in cardiovascular disease: Clinical significance and research tools
- Author
-
Uchmanowicz, Izabella, primary, Lisiak, Magdalena, additional, Wontor, Radosław, additional, Łoboz-Rudnicka, Maria, additional, Jankowska-Polańska, Beata, additional, Łoboz-Grudzień, Krystyna, additional, and Jaarsma, Tiny, additional
- Published
- 2015
- Full Text
- View/download PDF
26. Frailty and quality of life in elderly patients with acute coronary syndrome.
- Author
-
Lisiak, Magdalena, Uchmanowicz, Izabella, and Wontor, Radosław
- Subjects
FRAIL elderly ,ACUTE coronary syndrome ,AGING - Abstract
Background: Frail elderly people are at risk of developing adverse health outcomes such as disability, hospitalization, and mortality. In recent years, the literature has drawn attention to the role of frailty syndrome (FS) in acute coronary syndrome (ACS). There are few studies regarding the relationship between two multidimensional variables such as FS and quality of life (QoL). Objective: The aim of the study was to investigate the relationship between FS and early QoL of elderly patients with ACS (≥65 years old). Methods: The study was conducted among 91 patients aged 65 years and over with ACS. The MacNew questionnaire was used to evaluate QoL and the Tilburg frailty indicator to evaluate frailty. Results: FS was present in 82.4% of patients. The average Tilburg frailty indicator score was 7.43±2.57. A negative correlation between the global values of FS and QoL was shown (r=-0.549, P<0.05). The vulnerability factors that negatively affected early QoL were: FS, marital status, conservative therapy, and hypertension. In multivariate analysis, FS was found to be the independent predictor of worse QoL (β ± standard error -0.277±0.122, P=0.026). Conclusion: The presence of FS has a negative impact on early QoL in patients with ACS. The study suggests that in elderly patients with ACS, there is a need to identify frailty in order to implement additional therapeutic and nursing strategies in ACS. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
27. Zaburzenia snu a poziom samoopieki wsród chorych z niewydolnością serca.
- Author
-
Lomper, Katarzyna, Lamich, Karolina, Chudiak, Anna, Wleklik, Marta, Lisiak, Magdalena, and Uchmanowicz, Izabella
- Published
- 2018
28. Cognitive frailty in elderly patients with acute coronary syndrome.
- Author
-
Lisiak, Magdalena and Uchmanowicz, Izabella
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.